CNN
—
A brand new class of medicines referred to as glucagon-like peptide 1 receptor agonists, or GLP-1s, have surged in recognition by making weight reduction simpler for sufferers. The manufacturers — Wegovy and Zepbound for weight reduction and Ozempic and Mounjaro for sort 2 diabetes — have change into family names.
The medicine typically quiet “food noise,” or mind chatter about meals, and so they’ve been proven to impact heart disease and sleep apnea, amongst different situations. Customers, too, have reported modifications in addictive behaviors. Nevertheless, the medicine may be costly, difficult to find and to have some unwanted side effects, akin to gastrointestinal issues.
What are your questions on medicine and weight reduction? Share your questions with CNN beneath.